Detailed Information
Cited 16 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC)-A study by the Australasian Gastrointestinal Trials Group (AGITG), first results
- Authors
- Pavlakis, N[Pavlakis, Nick]; Sjoquist, KM[Sjoquist, Katrin Marie]; Tsobanis, E[Tsobanis, Eric]; Martin, A[Martin, Andrew]; Kang, YK[Kang, Yoon-Koo]; Bang, YJ[Bang, Yung-Jue]; O'Callaghan, CJ[O'Callaghan, Christopher J.]; Tebbutt, NC[Tebbutt, Niall C.]; Rha, SY[Rha, Sun Young]; Lee, J[Lee, Jeeyun]; Cho, JY[Cho, Jae Yong]; Lipton, LR[Lipton, Lara Rachel]; Burnell, MJ[Burnell, Margot J.]; Alcindor, T[Alcindor, Thierry]; Strickland, A[Strickland, Andrew]; Wong, M[Wong, Mark]; Kim, JW[Kim, Jin Won]; Simes, J[Simes, John]; Zalcberg, JR[Zalcberg, John Raymond]; Goldstein, D[Goldstein, David]
- Issue Date
- 20-Jan-2015
- Publisher
- AMER SOC CLINICAL ONCOLOGY
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.33, no.3
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 33
- Number
- 3
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.